Big Pharma Watch: Drug Makers Tone Deaf on Crisis of Affordability

08-22-2019 Blog Posts

BIO CEO Says Prescription Drugs Are Not Too Expensive If you needed any more evidence that Big Pharma is tone deaf to the growing crisis of rising prescription drug prices, look no further than a Tuesday C-SPAN interview with BIO President and CEO Jim Greenwood. During the interview, on C-SPAN’s “Washington Journal” program, Greenwood answers […]

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability

07-31-2019 Blog Posts

Q2 Earnings: Big Pharma Keeps Living the Good Life While Evading Accountability Drug Makers Sweep Profit Forecasts as Industry Continues to Price-Gouge American Patients   For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday following earnings announcements from 12 of the world’s […]

Big Pharma Earnings Watch: Amgen, Eli Lilly, Merck and Pfizer

07-31-2019 Blog Posts

Four More Rx Giants Complete the Sweep, Beat Q2 Earnings Forecasts After Hiking Prices   Over the past week, CSRxP has been tracking Q2 earnings for the biggest prescription drug manufacturers in the world. Yesterday, four more of these Big Pharma giants – Amgen, Eli Lilly, Merck and Pfizer – completed the sweep by reporting […]

Big Pharma Earnings Watch: AbbVie and Sanofi

07-30-2019 Blog Posts

Brand Name Drug Makers Continue to Surpass Q2 Forecasts After Hiking Prices   Pharmaceutical giants AbbVie and Sanofi kept the good times rolling for Big Pharma on Friday and Monday, with both besting earnings forecasts and raising outlooks for the remainder of the year. AbbVie reported $8.2 billion in sales, beating estimates of $8.1 billion […]

Big Pharma Earnings Watch: Bristol-Myers Squibb, AstraZeneca, Roche

07-29-2019 Blog Posts

Three More Drug Makers Top Earnings Expectations in Q2   Today three more price-gouging Big Pharma companies reported better-than-expected earnings in Q2 and raised forecasts for the rest of the year — after engaging in a frenzy of price hikes this year. Bristol-Myers Squibb reported revenues of $6.27 billion – 11 percent higher than predicted […]

Big Pharma Earnings Watch: GlaxoSmithKline

07-24-2019 Blog Posts

Big Pharma Giants Now Three for Three Besting Forecasts After Hiking Prices   More Big Pharma giants are reporting earnings this week for the second quarter of 2019. Today GlaxoSmithKline (GSK), one of the five largest drug manufacturers in the world, reported that revenue rose five percent in Q2, beating profit expectations. Sales were about […]

Second Opinion: Correcting Big Pharma’s Claims On The Rebate Rule

07-12-2019 Blog Posts

America’s seniors and taxpayers received a huge win today when the administration made the right call to withdraw a proposal, known as the Rebate Rule, from the Department of Health and Human Services (HHS). The Campaign for Sustainable Rx Pricing (CSRxP) was a leading voice raising concerns with the proposed rule, including, among others, its […]

CSRxP: STRONGER Patents Act Could Further Enable Big Pharma’s Patent Abuse

07-10-2019 Blog Posts

Proposed Bill Would Undermine Fair and Efficient Review Process For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) issued a statement today on the introduction of The Support Technology & Research for Our Nation’s Growth and Economic Resilience (STRONGER) Patents Act of 2019. “Inter partes reviews […]

THEY SAID IT! Senators on Aging Panel Pledge Bipartisan Action To Lower Drug Prices & Hold Big Pharma Accountable

06-20-2019 Blog Posts

For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]   Washington, D.C. – The U.S. Senate Special Committee on Aging held its third hearing on the “Complex Web of Prescription Drug Prices” on Wednesday.  Senators from both sides of the aisle called for action to lower drug prices for not only seniors, but all patients, and […]

Q1 Earnings Show Big Pharma Booming While American Patients Struggle

05-1-2019 Blog Posts

Largest Drug Makers Beat Profit Forecasts While Continuing To Price Gouge Patients For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Wednesday following earnings announcements from ten Big Pharma giants that showed they all surpassed profit forecasts for the first quarter of 2019. […]

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.